The distribution of capsular polysaccharide antigen (CHO) types, surface-exposed c proteins α (ca) and β (cb) and an R-protein antigen was examined in 334 group B streptococci (GBS) isolates from three groups of patients hospitalised in England and Wales or Norway. The isolates were from 108 carriers, 67 cases of neonatal infection and 154 cases of adult infection. Each group contained all CHO types (Ia, Ib, II, III, IV, V and NT); type III strains predominated except in the adult infected group. Strains within each CHO type could be further subdivided by the protein markers into five subtypes by a combined typing system. The proportion of type Ib and type III strains in the neonatal infection cases and of type Ib strains in the adult infection cases significantly outnumbered isolates of these serotypes among the carrier strains. Twenty-nine different serovariants were identified; 24, 13 and 23 serovariants among the carrier, neonatal infection and adult infection isolates, respectively. Certain CHO antigen-protein associations were identified, notably those between Ia/ca, Ib/cab and III/R. The proportion of invasive isolates that expressed protein was not higher than in the carrier isolates. All CHO-type Ib isolates contained a c protein, but 7 % of the Ib isolates did not contain any of these proteins. These findings indicate that this combined typing approach may be useful in examining epidemiological problems associated with GBS.
WalshJ. A.,
HutchinsS. Group B streptococcal disease: its importance in the developing world and prospect for prevention with vaccines. Pediatr Infect Dis J1989; 8:271–276
MusserJ. M.,
MattinglyS. J.,
QuentinR.,
GoudeauA.,
SelanderR. K. Identification of a high-virulence clone of type III Streptococcus agalactiae (group B streptococcus) causing invasive neonatal disease. Proc Natl Acad Sci USA1989; 86:4731–4735
DenningD. W.,
BakerC. J.,
TroupN. J.,
TompkinsL. S. Restriction endonuclease analysis of human and bovine group B streptococci for epidemiologic study. J Clin Microbiol1989; 27:1352–1356
FasolaE.,
LivdahlC.,
FerrieriP. Molecular analysis of multiple isolates of the major serotypes of group B streptococci. J Clin Microbiol1993; 31:2616–2620
JelínkovàJ.,
MatlovàJ. Worldwide distribution of two new serotypes of group B streptococci: type IV and provisional type V. J Clin Microbiol1985; 21:361–362
von HunolsteinC.,
D’AscenziS.,
WagnerB. Immuno-chemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci). Infect Immun1993; 61:1272–1280
LancefieldR. C.,
McCartyM.,
EverlyW. N. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J Exp Med1975; 142:165–179
BevangerL.,
IversenO. J. The Ibc protein fraction of group B streptococci: characterization of protein antigens extracted by Hcl. Acta Path Microbiol Scand Sect B1981; 89:205–209
HedénL.-O.,
FrithzE.,
LindahlG. Molecular characterization of an IgA receptor from group B streptococci: sequence of gene, identification of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity. Eur J Immunol1991; 21:1481–1490
MichelJ. L.,
MadoffL. C.,
OlsonK. Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci. Proc Natl Acad Sci USA1992; 89:10060–10064
FloresA. E.,
FerrieriP. Molecular species of R-protein antigens produced by clinical isolates of group B streptococci. J Clin Microbiol1989; 27:1050–1054
WilkinsonH. W.,
FacklamR. R.,
WorthamE. C. Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis). Infect Immun1973; 8:228–235
BevangerL.,
MaelandJ. A. Type classification of group B streptococci by the fluorescent antibody test. Acta Path Microbiol Scand Sect B1977; 85:357–362
NaessAl.,
BevangerL.,
IversenO.-J.,
MaelandJ. A. Evaluation of monoclonal antibodies in serovar classification of group B streptococci (GBS). APMIS1991; 99:1058–1060
BevangerL.,
IversenO.-J.,
NaessA. L. Characterization of the a antigen of the c proteins of group B streptococci (GBS) using a murine monoclonal antibody. APMIS1992; 100:57–62
KvamAl.,
BevangerL. S.,
IversenO.-J. Characterization of a surface protein of group B streptococci resembling the a antigen of the c proteins. In
TotolianA.
(ed) Pathogenic streptococci in present and future St Petersburg: Lancer Publications; 1994337
Stalhammar-CarlemalmM.,
StenbergL.,
LindahlG. Protein Rib. A novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J Exp Med1993; 177:1593–1603
ChunC. S. Y.,
BradyL. F.,
BoyleM. D. P.,
DillonH. C.,
AyoubE. M. Group B streptococcal c protein-associated antigens: association with neonatal sepsis. J Infect Dis1991; 163:786–791
HervasJ. A.,
GonzalezL.,
GilJ.,
PaolettiL. C.,
MadoffL. C.,
BenediV. J. Neonatal group B streptococcal infection in Mallorca, Spain. Clin Infect Dis1993; 16:714–718
BakerC. J.,
EdwardsM. S. Group B streptococcal infections. In
RemingtonJ. S.,
KleinJ. O.
(eds) Infectious diseases of the fetus and newborn infant 3rd edn Philadelphia W. B.: Saunders Company; 1990742–811
BevangerL.,
NaessA. L Mouse protective antibodies against the Ibc proteins of group B streptococci. Acta Pathol Microbiol Immunol Scand Sect B1985; 93:121–124
MichelJ. L.,
MadoffL. C.,
KlingD. E.,
KasperD. L.,
AusubelF. M. Cloned alpha and beta c-protein antigens of group B streptococci elicit protective immunity. Infect Immun1991; 59:2023–2028